Covaxin Supply
- All
- News
- Videos
-
"Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid...": Centre
Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
-
No Doubts On Safety, Efficacy: WHO Chief Scientist On Covaxin Suspension
Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
-
Vaccine Not Sent To UN Bodies, Says Bharat Biotech On WHO Action: Sources
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
75 Million Covaxin Doses Supplied, Says Bharat Biotech
Bharat Biotech on Thursday informed that the Hyderabad- based company has till now supplied 75 million doses of its Covid-19 vaccine Covaxin and more will be supplied this month.
-
"Quality Issues Behind Covaxin Shortage": Government Vaccine Panel Chief
The supply of Bharat Biotech's Covaxin has been slowed down because the first few batches at the company's newest facility in Bengaluru were not of the right quality, a top government adviser has said.
-
Bharat Biotech Commits 500 Million Doses Of Covaxin To Centre
Bharat Biotech today said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme.
-
Centre To Buy 66 Crore More Doses Of Covishield, Covaxin At Revised Rates: Report
The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources said.
-
Punjab Running Out Of Vaccines, Calls For Increase In Supply From Centre
With Punjab running out of coronavirus vaccine Covishield and left with only one day's stock of Covaxin, Chief Minister Amarinder Singh today reiterated the need for enhanced supplies from the Centre, his office said.
-
"Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid...": Centre
Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
-
No Doubts On Safety, Efficacy: WHO Chief Scientist On Covaxin Suspension
Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
-
Vaccine Not Sent To UN Bodies, Says Bharat Biotech On WHO Action: Sources
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
75 Million Covaxin Doses Supplied, Says Bharat Biotech
Bharat Biotech on Thursday informed that the Hyderabad- based company has till now supplied 75 million doses of its Covid-19 vaccine Covaxin and more will be supplied this month.
-
"Quality Issues Behind Covaxin Shortage": Government Vaccine Panel Chief
The supply of Bharat Biotech's Covaxin has been slowed down because the first few batches at the company's newest facility in Bengaluru were not of the right quality, a top government adviser has said.
-
Bharat Biotech Commits 500 Million Doses Of Covaxin To Centre
Bharat Biotech today said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme.
-
Centre To Buy 66 Crore More Doses Of Covishield, Covaxin At Revised Rates: Report
The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources said.
-
Punjab Running Out Of Vaccines, Calls For Increase In Supply From Centre
With Punjab running out of coronavirus vaccine Covishield and left with only one day's stock of Covaxin, Chief Minister Amarinder Singh today reiterated the need for enhanced supplies from the Centre, his office said.
